Viewing Study NCT03606967


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2025-12-25 @ 11:09 PM
Study NCT ID: NCT03606967
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2018-07-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module